A randomized study comparing the efficacy of reducing the spontaneous abortion rate following lymphocyte immunotherapy and progesterone treatment versus progesterone alone in primary habitual aborters
- PMID: 7635369
- DOI: 10.1159/000292421
A randomized study comparing the efficacy of reducing the spontaneous abortion rate following lymphocyte immunotherapy and progesterone treatment versus progesterone alone in primary habitual aborters
Abstract
Presented herein is a randomized prospective study performed to evaluate the efficacy of the addition of lymphocyte immunotherapy (LI) to progesterone (P) therapy (LI/P) for the prevention of spontaneous abortion (SAB) in primary aborters with a history of three SABs. The incidence of intrauterine pregnancies in four cycles was 23 of 35 (65.7%) patients for LI/P vs. 14 of 31 (45.1%) patients treated with progesterone alone. SABs occurred in 6 of 23 (26.0%) LI/P-treated patients compared to 8 of 14 (57.1%) given progesterone alone. The mean number of previous abortions in both groups was 3.9. The mean age of the LI/P group was 34.1 vs. 33.6 years for the group treated with progesterone alone. These data could be interpreted to show that progesterone therapy and LI independently inhibit SAB or that LI/P acts synergistically to inhibit immune destruction. LI/P therapy was found to be more effective than progesterone therapy alone.
Similar articles
-
A practical approach to the prevention of miscarriage: part 2--active immunotherapy.Clin Exp Obstet Gynecol. 2010;37(1):5-9. Clin Exp Obstet Gynecol. 2010. PMID: 20420268
-
Immunological characteristics of nonpregnant women with unexplained recurrent spontaneous abortion who underwent paternal lymphocytes immunization.Zentralbl Gynakol. 1998;120(10):493-502. Zentralbl Gynakol. 1998. PMID: 9823650
-
Progesterone therapy to decrease first-trimester spontaneous abortions in previous aborters.Int J Fertil. 1987 May-Jun;32(3):192-3, 197-9. Int J Fertil. 1987. PMID: 2885282
-
Progesterone-mediated immunomodulation in pregnancy: its relevance to leukocyte immunotherapy of recurrent miscarriage.Immunotherapy. 2009 Sep;1(5):873-82. doi: 10.2217/imt.09.54. Immunotherapy. 2009. PMID: 20636029 Review.
-
[Immunologic diagnosis and therapy in habitual abortion].Wien Med Wochenschr. 1990;140(22):547-50. Wien Med Wochenschr. 1990. PMID: 2080628 Review. German.
Cited by
-
Progestogen for preventing miscarriage in women with recurrent miscarriage of unclear etiology.Cochrane Database Syst Rev. 2019 Nov 20;2019(11):CD003511. doi: 10.1002/14651858.CD003511.pub5. Cochrane Database Syst Rev. 2019. PMID: 31745982 Free PMC article.
-
Progestogen for treating threatened miscarriage.Cochrane Database Syst Rev. 2018 Aug 6;8(8):CD005943. doi: 10.1002/14651858.CD005943.pub5. Cochrane Database Syst Rev. 2018. PMID: 30081430 Free PMC article.
-
Immunotherapy for recurrent miscarriage.Cochrane Database Syst Rev. 2014 Oct 21;2014(10):CD000112. doi: 10.1002/14651858.CD000112.pub3. Cochrane Database Syst Rev. 2014. PMID: 25331518 Free PMC article. Review.
-
Progestogen for preventing miscarriage in women with recurrent miscarriage of unclear etiology.Cochrane Database Syst Rev. 2018 Oct 8;10(10):CD003511. doi: 10.1002/14651858.CD003511.pub4. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2019 Nov 20;2019(11). doi: 10.1002/14651858.CD003511.pub5. PMID: 30298541 Free PMC article. Updated.
-
Care prior to and during subsequent pregnancies following stillbirth for improving outcomes.Cochrane Database Syst Rev. 2018 Dec 17;12(12):CD012203. doi: 10.1002/14651858.CD012203.pub2. Cochrane Database Syst Rev. 2018. PMID: 30556599 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources